Hence, although IFN-gamma has the potential to increase tumor regression and anti-PD-L1 treatment efficacy, drawbacks warn about the potential anti-viral and tumor-enhancing side effects of IFN-gamma relating to dosage. Here, IFNG is linked to neoplasm.